Editas Medicine (EDIT) Shares Plunge Amid Biotech Sector Fluctuations

Shares of Editas Medicine, Inc. (EDIT, Financial), a biopharmaceutical company, experienced a notable drop of 5.18%. The stock is currently priced at $3.21 per share, with a trading volume of 976,255 shares and a turnover rate of 1.18$513,000 in revenue but reported a net loss of $67.61 million. The earnings per share stood at -$0.82, and the gross profit was -$907,000, resulting in a priceto-earnings ...